Department of Anatomic Pathology, School of Medical Sciences, State University of Campinas (Unicamp), Sao Paulo, Brazil.
Int Braz J Urol. 2013 May-Jun;39(3):320-7. doi: 10.1590/S1677-5538.IBJU.2013.03.04.
There is evidence that reactive stroma in different cancers may regulate tumor progression. The aim of this study is to establish any possible relation of reactive stroma grading on needle prostatic biopsies to biochemical recurrence.
The study group comprised 266 biopsies from consecutive patients submitted to radical prostatectomy. Reactive stroma was defined as stroma surrounding neoplastic tissue and graded as 0 (absent), 1 (slight), 2 (moderate), and 3 (intense) according to tumor stroma area relative to total tumor area.
From the total of 266 needle prostatic biopsies, 143 (53.8%), 55 (20.7%), 54 (20.3%), and 14 (5.3%) showed grades 0, 1, 2, and 3, respectively. Increasing reactive stroma grade was significantly associated with clinical stage T2, higher preoperative PSA, higher biopsy and radical prostatectomy Gleason score, more extensive tumors in radical prostatectomy, and pathologic stage > T2. Only grade 3 was significantly associated with time and risk to biochemical recurrence. On multivariate analysis only preoperative PSA and 2 methods of biopsy tumor extent evaluation were independent predictors.
Increasing reactive stroma grade on biopsies is significantly associated with several clinicopathologic adverse findings, however, only grade 3 predicts time and risk to biochemical recurrence following radical prostatectomy on univariate but not on multivariate analysis. We have not been able to show that reactive stroma grade 3 on biopsies is an independent predictor of biochemical recurrence beyond that of preoperative PSA and other pathologic findings on biopsy.
有证据表明,不同癌症中的反应性基质可能调节肿瘤进展。本研究旨在确定前列腺针吸活检中反应性基质分级与生化复发之间的任何可能关系。
研究组包括 266 例连续接受根治性前列腺切除术的患者的活检标本。根据肿瘤与总肿瘤面积的相对比例,将反应性基质定义为包围肿瘤组织的基质,并分为 0(无)、1(轻微)、2(中度)和 3(强烈)。
在总共 266 例前列腺针吸活检中,分别有 143 例(53.8%)、55 例(20.7%)、54 例(20.3%)和 14 例(5.3%)显示为 0、1、2 和 3 级。反应性基质分级增加与临床分期 T2、术前 PSA 升高、活检和根治性前列腺切除术 Gleason 评分升高、根治性前列腺切除术肿瘤范围更广以及病理分期>T2 显著相关。仅 3 级与生化复发的时间和风险显著相关。多变量分析仅术前 PSA 和 2 种活检肿瘤范围评估方法是独立预测因素。
活检中反应性基质分级的增加与多种临床病理不良发现显著相关,但仅 3 级在单变量分析中预测根治性前列腺切除术后生化复发的时间和风险,而在多变量分析中则不然。我们还未能证明活检中反应性基质 3 级是除术前 PSA 和其他活检病理发现之外生化复发的独立预测因素。